摘要
目的:探讨奥氮平、利培酮和阿立哌唑三种非典型抗精神病药对首发精神分裂症患者认知功能的影响。方法:91例首发精神分裂症患者通过多中心随机分配,奥氮平组(n=27)、利培酮组(n=37)和阿立哌唑组(n=27),在治疗前和12周后完成如下测评:阳性与阴性症状量表(Positive and Negative Syndrome Scale,PANSS)、韦氏记忆量表-第三版(Wechsler Memory Scale,WMS-Ⅲ)的空间广度测验、霍普金斯词汇学习测验-修订版(Hopkins Verbal Learning Test-Revised,HVLT-R)。结果:①治疗12周后,三组PANSS评分均较治疗前显著降低(P<0.001),三组间PANSS减分率的差异无统计学显著性。②空间广度方面,阿立哌唑组治疗后的顺行得分和总分(8.48±2.26,15.59±3.61)较治疗前(7.52±1.72,14.11±3.63)显著增加(P<0.05),奥氮平组和利培酮组前后比较差异均无统计学显著性(P>0.05)。③HVLT-R得分方面,奥氮平组和利培酮组治疗后即刻回忆数、回忆总数和再认得分较治疗前显著增加(P<0.05～0.01),阿立哌唑组治疗后HVLT-R的所有得分均较治疗前显著增加(P<0.05～0.01),三组患者即刻回忆数、回忆总数和再认的改善值比较差异均无统计学显著性(P>0.05)。结论:阿立哌唑对首发精神分裂症患者记忆功能的改善在一定程度上优于奥氮平和利培酮。
Objective：To explore the efficacy of olanzapine,risperidone and aripiprazole on memory function in patients with first-episode schizophrenia.Methods：91 first-episode patients with schizophrenia were randomized to olanzapine group（n=27）,risperidone group（n=37） and aripiprazole group（n=27）.All subjects were assessed with Positive and Negative Syndrome Scale（PANSS）,Hopkins Verbal Learning Test-Revised（HVLT-R）,Wechsler Memory Scale-Ⅲ（WMS-Ⅲ） and Spatial Span Task.Results：①Compared with the baseline,all the scores of PANSS decreased significantly（P〈0.001）,but no significant difference was found among the three groups（P〉0.05）.②Compared with the baseline,the total score and the Anterograde score of Spatial Span Test increased significantly（P〈0.05） in aripiprazole group,but no significant changes were found in olanzapine group and risperidone group（P〉0.05）.③Compared with the baseline,the scores of immediate recall,total recall and recognition about HVLT-R increased significantly（P〈0.05～0.01） in olanzapine group and risperidone group,and all the scores of HVLT-R increased significantly（P〈0.05～0.01） in aripiprazole group,but no significant difference was found among the three groups（P〉0.05）.Conclusion：The improvement in memory function of aripiprazole would be probably better than olanzapine and risperidone.
出处
《中国临床心理学杂志》
CSSCI
CSCD
2011年第1期59-62,84,共5页
Chinese Journal of Clinical Psychology
基金
“十一五”国家科技支撑课题“精神分裂症早期诊断技术与规范化治疗研究”
